Skip to main content
VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.590
-0.005 (-0.82%)
At close: Mar 9, 2026, 4:00 PM EDT
0.585
-0.005 (-0.88%)
After-hours: Mar 9, 2026, 5:28 PM EDT

VYNE Therapeutics Revenue

In the year 2025, VYNE Therapeutics had annual revenue of $570.00K with 13.77% growth. VYNE Therapeutics had revenue of $130.00K in the quarter ending December 31, 2025, with 54.76% growth.

Revenue (ttm)
$570.00K
Revenue Growth
+13.77%
P/S Ratio
33.91
Revenue / Employee
$43,846
Employees
13
Market Cap
19.67M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025570.00K69.00K13.77%
Dec 31, 2024501.00K77.00K18.16%
Dec 31, 2023424.00K-53.00K-11.11%
Dec 31, 2022477.00K-454.00K-48.76%
Dec 31, 2021931.00K-20.06M-95.57%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

VYNE News

More News